Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sep 2019 4:00 AM GMTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India Farhat Nasim2 March 2019 5:30 AM GMT"Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar...